Zinc and copper status in hemoglobin H disease and beta-thalassemia/hemoglobin E disease.
The plasma zinc and copper and urinary zinc levels were determined by an atomic absorption spectrophotometer technic in 14 patients with hemoglobin (Hb) H disease, 34 patients with beta-thalassemia/Hb E disease and 30 control subjects. Plasma zinc levels were lower and the plasma copper levels were higher in the patients than in controls. The plasma Cu:Zn ratios, a more valuable indicator of body zinc status, increased in the diseased subjects, indicating zinc deficiency. Higher urinary zinc levels in the both Hb H disease and 30 control subjects. Plasma zinc levels were lower and the plasma copper levels were higher in the patients than in controls. The plasma Cu:Zn ratios, a more valuable indicator of body zinc status, increased in the diseased subjects, indicating zinc deficiency. Higher urinary zinc levels in the both Hb H disease and 30 control subjects. Plasma zinc levels were lower and the plasma copper levels were higher in the patients than in controls. The plasma Cu:Zn ratios, a more valuable indicator of body zinc status, increased in the diseased subjects, indicating zinc deficiency. Higher urinary zinc levels in the both Hb H disease and beta-thalassemia/Hb E disease suggest that chronic hemolysis is responsible for hyperzincuria leading to zinc deficiency. The thalassemic patients with undergrowth had higher plasma Cu:Zn ratios than the patients with normal development, indicating a more severe zinc deficiency in the former.
D000293:Adolescent; D000328:Adult; D002648:Child; D003300:Copper / Q000097:blood*; D005260:Female; D006130:Growth Disorders / Q000150:complications; D006446:Hemoglobin E; D006801:Humans; D008297:Male; D008875:Middle Aged; D013789:Thalassemia / Q000150:complications / Q000378:metabolism*; D015032:Zinc / Q000097:blood / Q000378:metabolism* / Q000652:urine
D003300:Copper; D006446:Hemoglobin E; D015032:Zinc